Psychiatric disorders and sexual dysfunction

Handbook of Clinical Neurology

Volumn 130, Issue , 2015, Pages 469-489

  Waldinger, Marcel D ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FEMALE; HUMAN; MALE; PSYCHOSEXUAL DISORDER;

FEMALE; HUMANS; MALE; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

EID: 84942517242     PISSN: 00729752     EISSN: 22124152     Source Type: Book Series    
DOI: None     Document Type: Chapter

References (207)

1. Ahlenius S, Larsson K, Svensson L et al. (1981). Effects of a new type of 5-HT receptor agonist on male rat sexual behavior. Pharmacol Biochem Behav 15: 785-792.
2. Ahmad S (1995). Paroxetine-induced priapism. Arch Intern Med 155: 645.
3. Aizenberg D, Zemishlany Z, Dorfman-Etrog P et al. (1995). Sexual dysfunction in male schizophrenic patients. J Clin Psychiatry 56: 137-141.
4. Aizenberg D, Modai I, Landa A et al. (2001). Comparison of sexual dysfunction in male schizophrenic patients maintained on treatment with classical antipsychotics versus clozapine. J Clin Psychiatry 62: 541-544.
5. Akhtar S, Thomson JA (1980). Schizophrenia and sexuality; review and a report of 12 unusual cases-part 2. J Clin Psychiatry 56: 137-141.
6. Aksaray G, Yelken B (2001). Sexuality in women with obsessive compulsive disorder. J Sex Marital Ther 27: 273-277.
7. Aksoy UM, Aksoy SG, Maner F et al. (2012). Sexual dysfunction in obsessive compulsive disorder and panic disorder. Psychiatr Danub 24: 381-385.
8. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th Ed, APA, Washington DC (DSM-IV).
9. American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, 5th Ed, APA, Washington DC (DSM-5).
10. Angrist B, Gershon S (1977). Clinical response to several dopamine agonists of schizophrenic and non-schizophrenic subjects. Adv Biochem Psychopharmacol 16: 677-680.
11. Angst J (1998). Sexual problems in healthy and depressed persons. Int Clin Psychopharmacol 13 (Suppl 6): S1-S4.
12. Apt C, Hurlbert DF (1994). The sexual attitudes, behavior, and relationships of women with histrionic personality disorder. J Sex Marital Ther 20: 125-133.
13. Araujo AB, Durante R, Feldman HA et al. (1998). The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study. Psychosom Med 60: 458-465.
14. Ariety S (1967). Sexual conflicts in psychotic disorders. In: Sexual Problems: Diagnosis and Treatment in Medical Practice, Free Press, Wahl C. New York.
15. Baggaley M (2008). Sexual dysfunction in schizophrenia: locus on recent evidence. Hum Psychopharmacol 23: 201-209.
16. Baldwin DS (2004). Sexual dysfunction associated with antidepressant drugs. Expert Opin Drug Saf 3: 457-470.
17. Balon R, Segraves RT (2008). Survey of treatment practices for sexual dysfunction(s) associated with antidepressants. J Sex Marital Ther 34: 353-365.
18. Balon R, Yeragani VK, Pohl R (1980). Sexual dysfunction during antidepressant treatment. J Clin Psychiatry 41: 351-354.
19. Bandini E, Corona G, Ricca V et al. (2009). Hysterical traits are not from the uterus but from the testis: a study in men with sexual dysfunction. J Sex Med 6: 2321-2331.
20. Berendsen HHG, Broekkamp CLE (1990). Involvement of 5-HT1C receptors in drug-induced penile erections in rats. Psychopharmacology (Berl) 101: 57-61.
21. Bijlsma EY, Chan JS, Olivier B et al. (2014). Sexual side effects of serotonergic antidepressants: mediated by inhibition of serotonin on central dopamine release? Pharmacol Biochem Behav 121: 88-101.
22. Bitter I, Basson BR, Dossenbach MR (2005). Antipsychotic treatment and sexual functioning in first-time neuroleptic-treated schizophrenic patients. Int Clin Psychopharmacol 20: 19-21.
23. Bloemers J, van Rooij K, Poels S et al. (2013). Toward personalized sexual medicine (part 1): integrating the "dual control model" into differential drug treatments for hypoactive sexual desire disorder and female sexual arousal disorder. J Sex Med 10: 791-809.
24. Bodinger L, Hermesh H, Aizenberg D et al. (2002). Sexual function and behavior in social phobia. J Clin Psychiatry 63: 874-879.
25. Bolton JM, Sareen J, Reiss JP (2006). Genital anaesthesia persisting six years after sertraline discontinuation. J Sex Marital Ther 32: 327-330.
26. Bonnot O, Warot D, Cohen D (2007). Priapism associated with sertraline. J Am Acad Child Adolesc Psychiatry 46: 790-791.
27. Buddeberg C, Furrer H, Limbacher B (1988). Sexuelle Schwierigkeiten ambulant behandelter Schizophrener. Psychiatr Prax 15: 187-191.
28. Carro-Juarez M, Rodriguez-Manzo G (2008). The spinal pattern generator for ejaculation. Brain Res Rev 58: 106-120.
29. Casper RC, Redmond DE, Katz MM et al. (1985). Somatic symptoms in primary affective disorder. Arch Gen Psychiatry 42: 1098-1104.
30. Chen KC, Yeh TL, Lee IH et al. (2009). Age gender, depression, and sexual dysfunction in Taiwan. J Sex Med 6: 3056-3062.
31. Clark SL, Adkins DE, Aberg K et al. (2012). Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D. Psychol Med 42: 1151-1162.
32. Clayton AH, Pradko JF, Croft HA et al. (2002). Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry 63: 357-366.
33. Clayton AH, Zajecka J, Ferguson JM et al. (2003). Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder. Int Clin Psychopharmacol 18: 151-156.
34. Clayton AH, Croft HA, Horrigan JP et al. (2006). Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies. J Clin Psychiatry 67: 736-746.
35. Clayton AH, Kennedy SH, Edwards JB et al. (2013). The effect of vilazodone on sexual function during the treatment of major depressive disease. J Sex Med 10: 2465-2476.
36. Coleman CC, King BR, Bolden-Watson C et al. (2001). A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine. Clin Ther 23: 1040-1058.
37. Connolly FH, Gittleson NL (1971). The relationship between delusions of sexual change and olfactory and gustatory hallucinations in schizophrenia. Br J Psychiatry 119: 443-444.
38. Coolen LM, Allard J, Truitt WA et al. (2004). Central regulation of ejaculation. Physiol Behav 83: 203-215.
39. Csoka AB, Shipko S (2006). Persistent sexual side effects after SSRI discontinuation (Letter). Psychother Psychosom 75: 187-188.
40. Csoka AB, Bahrick AS, Mehtonen OP (2008). Persistent sexual dysfunction after discontinuation of selective serotonin reuptake inhibitors (SSRIs). J Sex Med 5: 227-233.
41. Cutler AJ (2003). Sexual dysfunction and antipsychotic treatment. Psychoneuroendocrinology 28: 69-82.
42. Cyranowski JM, Bromberger J, Youk A (2004). Lifetime depression history and sexual function in women at midlife. Arch Sex Behav 33: 539-548.
43. de Jong TR, Veening JG, Waldinger MD et al. (2006a). Serotonin and the neurobiology of the ejaculatory threshold. Neurosci Biobehav Rev 30: 893-907.
44. de Jong TR, Snaphaan LJ, Pattij T et al. (2006b). Effects of chronic treatment with fluvoxamine and paroxetine during adolescence on serotonin-related behavior in adult male rats. Eur Neuropsychopharmacol 16: 39-48.
45. Deissenhammer EA, Trawoger R (1999). Penile anesthesia associated with sertraline use (Letter). J Clin Psychiatry 60: 869-870.
46. Delgrado PL, Brannan SK, Mallinckrodt CH et al. (2005). Sexual functioning assessed in 4 double-blind placeboand paroxetine-controlled trials of duloxetine for major depressive disorder. J Clin Psychiatry 66: 686-692.
47. Dent LA, Brown WC, Murney JD (2002). Citalopram-induced priapism. Pharmacotherapy 22: 538-541.
48. Derogatis LR, Burnett AL (2008). The epidemiology of sexual dysfunctions. J Sex Med 5: 289-300.
49. Dossenbach M, Hodge A, Anders M et al. (2005). Prevalence of sexual dysfunction in patients with schizophrenia: international variation and underestimation. Int J Neuropsychopharmacol 8: 195-201.
50. Dossenbach M, Dyachkova Y, Pirildar S et al. (2006). Effects of atypical and typical antipsychotic treatments on sexual function in patients with schizophrenia: 12-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study. Eur Psychiatry 21: 251-258.
51. Ellison JM, DeLuca P (1998). Fluoxetine-induced genital anesthesia relieved by Ginkgo biloba extract (letter). J Clin Psychiatry 59: 199-200.
52. Farnsworth KD, Dinsmore WW (2009). Persistent sexual dysfunction in genitourinary medicine clinic attendees induced by selective serotonin reuptake inhibitors (Letter). Int J STD AIDS 20: 68-69.
53. Feldman HA, Goldstein I, Hatzichristou DG et al. (1994). Impotence and its medical and psychosocial correlates: results of t he Mas sac huse tt s Ma le Aging Study. J Ur ol 151: 54-61.
54. Figueira I, Possidente E, Marques C et al. (2001). Sexual dysfunction: a neglected complication of panic disorder and social phobia. Arch Sex Behav 30: 369-377.
55. Finn SE, Baily JM, Schultz RT et al. (1990). Subjective utility ratings of neuroleptics in treating schizophrenia. Psychiatry Med 35: 843-848.
56. Fontenelle LF, de Souza WF, de Menezes GB et al. (2007). Sexual function and dysfunction in Brazilian patients with obsessive-compulsive disorder and social anxiety disorder. J Nerv Ment Dis 195: 254-257.
57. Fortier P, Trudel G, Mottard JP et al. (2000). The influence of schizophrenia and standard or atypical neuroleptics on sexual and sociosexual functioning: a review. Sexuality and Disability 18: 85-104.
58. Freund B, Steketee G (1989). Sexual history, attitudes and functioning of obsessive-compulsive patient. J Sex Marital Ther 15: 31-41.
59. Gessa GL, Tagliamonte A (1974). Possible role of brain serotonin and dopamine in controlling male sexual behavior. Adv Biochem Psychopharmacol 11: 217-227.
60. Ghadirian AM, Chouinard G, Annable L (1982). Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients. J Nerv Ment Dis 170: 463-467.
61. Gorton G, Akhtar S (1990). The literature on personality disorders, 1985-88: trends, issues and controversies. Hosp Community Psychiatry 41: 39-51.
62. Graf H, Walter M, Metzger CD et al. (2014). Antidepressantrelated sexual dysfunction-Perspectives from neuroimaging. Pharmacol Biochem Behav 121: 138-145.
63. Haddad PM, Sharma SG (2007). Adverse effects of atypical antipsychotics: differential risk and clinical implications. CNS Drugs 21: 911-936.
64. Hammer M (2002). The effect of atypical antipsychotics on serum prolactin levels. Ann Clin Psychiatry 14: 163-173.
65. Harrison WM, Rabkin JG, Ehrhardt AA et al. (1986). Effects of antidepressant medications on sexual function: a controlled study. J Clin Psychopharmacol 6: 144-149.
66. Hayes RD, Dennerstein L, Bennett CM et al. (2008). What is the "true" prevalence of female sexual dysfunctions and does the way we assess these conditions have an impact? J Sex Med 5: 777-787.
67. Hilger T, Propping P, Haverkamp F (1983). Is there an increase in reproductive rates in schizophrenics? An investigation in Nordbaden (SW Germany): Results and discussion. Arch Psychiatr Nervenkr: 177-186.
68. Hull JW, Clarkin JF, Yeomans F (1993). Borderline personality disorder and impulsive sexual behavior. Hosp Community Psychiatry 44: 1000-1002.
69. Hummer M, Kemmler G, Kurz M et al. (1999). Sexual disturbances during clozapine and haloperidol treatment for schizophrenia. Am J Psychiatry 156: 631-633.
70. Hurlbert DF, Apt C (1991). Sexual narcissism and the abusive male. J Sex Marital Ther 17: 279-292.
71. Hurlbert DF, Apt CV, White LC (1992). An empirical examination into the sexuality of women with borderline personality disorder. J Sex Marital Ther 18: 231-242.
72. Hyppa MT, Rinne VK, Sonninen V (1970). The activating effect of L-dopa treatment on sexual function and its experimental background. Acta Neurol Scand 43 (Suppl 43): 232-234.
73. Jacobs P, Bobek SC (1991). Sexual needs of the schizophrenic client. Perspect Psychiatr Care 27: 15-20.
74. Janssen PK, Bakker SC, Réthelyi J et al. (2009). Serotonin transporter promoter region (5-HTTLPR) polymorphism is associated with the intravaginal ejaculation latency time in Dutch men with lifelong premature ejaculation. J Sex Med 6: 276-284.
75. Janssen PK, van Schaik R, Zwinderman AH et al. (2014a). The 5-HT1A receptor C(1019)G polymorphism influences the intravaginal ejaculation latency time in Dutch Caucasian men with lifelong premature ejaculation. Pharmacol Biochem Behav 21: 184-188.
76. Janssen PK, Rv Schaik, Olivier B et al. (2014b). The 5-HT2C receptor gene Cys23Ser polymorphism influences the intravaginal ejaculation latency time in Dutch Caucasian men with lifelong premature ejaculation. Asian J Androl 16: 607-610.
77. Janssen PK, Zwinderman AH, Olivier B et al. (2014c). Serotonin transporter promoter region (5-HTTLPR) polymorphism is not associated with paroxetine-induced ejaculation delay in Dutch men with lifelong premature ejaculation. Korean J Urol 55: 129-133.
78. Jonusiene G, Griffioen T (2013). Psychiatric disorders and sexual dysfunctions. In: PS Kirana, F Tripodi, Y Reisman, H Porst (Eds.), The EFS and ESSM Syllabus of Clinical Sexology: ESSM Educational Committee, Medix Publishers. Amsterdam, The Netherlands, pp. 380-927.
79. Kaplan HS (1988). Anxiety and sexual dysfunction. J Clin Psychiatry 49: 21-25.
80. Kem DL, Posey DJ, McDougle CJ (2002). Priapism associated with trazodone in an adolescent with autism. J Am Acad Child Adolesc Psychiatry 41: 758.
81. Kennedy SH, Rizvi S (2009). Sexual dysfunction, depression, and the impact of antidepressants. J Clin Psychopharmacol 29: 157-164.
82. Kennedy SH, Dickens SE, Eisfeld BS et al. (1999). Sexual dysfunction before antidepressant therapy in major depression. J Affect Disord 56 (2-3): 201-208.
83. Kennedy SH, Fulton KA, Bagby RM et al. (2006). Sexual function during bupropion or paroxetine treatment of major depressive disorder. Can J Psychiatry 51: 234-242.
84. Kennedy SH, Rizvi S, Fulton K et al. (2008). A double-blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR. J Clin Psychopharmacol 28: 329-333.
85. Kessler RC, Walters EE (1998). Epidemiology of DSM-III-R major depression and minor depression among adolescents and young adults in the National Comorbidity Survey. Depress Anxiety 7: 3-14.
86. Kessler RC, Berglund P, Demler O et al. (2003). The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289: 3095-3105.
87. Khan A, Cutler AJ, Kajdasz DK et al. (2011). A randomized, double-blind, placebo-controlled, 8-week study of vilazodone, a serotonergic agent for the treatment of major depressive disorder. J Clin Psychiatry 72: 441-447.
88. Kim W, Jin BR, Yang WS et al. (2009). Treatment with selective serotonin reuptake inhibitors and mirtapazine results in differential brain activation by visual erotic stimuli in patients with major depressive disorder. Psychiatry Investig 6: 85-95.
89. King jr VL, Horowitz IR (1993). Vaginal anesthesia associated with fluoxetine use (letter). Am J Psychiatry 150: 984-985.
90. Kleinberg DK, Davis JM, de Coster R et al. (1999). Prolactin levels and adverse events in patients treated with risperidone. J Clin Psychopharmacol 19: 57-61.
91. Knegtering R, de Boer M (2012).In: R Knegtering, M de Boer (Eds.), Antipsychotic Treatment and Sexual Functioning: Role of Prolactin and Dopamine, Third Edition, Oce Business Services, The Netherlands.
92. Knegtering H, Castelein S, Bous H et al. (2004). A randomized open-label study of the impact of quetiapine versus olanzapine on sexual functioning. J Clin Psychopharmacol 24: 56-61.
93. Kotler M, Cohen H, Aizenberg D et al. (2000). Sexual dysfunction in male posttraumatic stress disorder patients. Psychother Psychosom 69: 309-315.
94. Langworth S, Bodlund O, Agren H (2006). Efficacy and tolerability of reboxetine compared with citalopram: a doubleblind study in patients with major depressive disorder. J Clin Psychopharmacol 26: 121-127.
95. LaTorre A, Giupponi G, Duffy D et al. (2013). Sexual dysfunction related to psychotrophic drugs: a critical review-part 1: antidepressants. Pharmacopsychiatry 46: 191-199.
96. Laumann EO, Paik A, Rosen RC (1999). Sexual dysfunction in the United States: prevalence and predictors. JAMA 281: 537-544.
97. Laurent SM, Simons AD (2009). Sexual dysfunction in depression and anxiety: conceptualizing sexual dysfunction as part of an internalizing dimension. Clin Psychol Rev 29: 573-585.
98. Lee TI, Issac J, Lin SH et al. (2013). Gender difference in antidepressant-related sexual dysfunction in Taiwan. Gen Hosp Psychiatry 35: 407-411.
99. Letourneau EJ, Schewe PA, Frueh BC (1997). Preliminary evaluation of sexual problems in combat veterans with PTSD. J Trauma Stress 10: 125-132.
100. Lewis RW, Fugl-Meyer KS, Corona G et al. (2010). Definitions/epidemiology/risk factors for sexual dysfunction. J Sex Med 7: 1598-1607.
101. Liang C-S, Ho P-S, Chiang K-T et al. (2012). 5-HT2A receptor 1438 G/A polymorphism and serotonergic antidepressantinduced sexual dysfunction in male patients with major depressive disorder: a prospective exploratory study. J Sex Med 9: 2009-2016.
102. Lin CF, Juang YY, Wen JK et al. (2012). Correlations between sexual dysfunction, depression, anxiety, and somatic symptoms among patients with major depressive disorder. Chang Gung Med J 35: 323-331.
103. Lyketsos GC, Sakka P, Mailis A (1983). The sexual adjusment of chronic schizophrenics: a preliminary study. Br J Psychiatry 143: 376-382.
104. MacDonald S, Halliday J, MacEwan T et al. (2003). Nithsdale schizophrenia surveys 24: sexual dysfunction. Br J Psychiatry 182: 50-56.
105. MacLean PD (1975). Brain mechanisms of primal sexual functions and related behavior. In: M Sandler, GL Gessa (Eds.), Sexual behavior: pharmacology and biochemistry, Raven Press, New York, pp. 1-11.
106. Marberger H (1974). The mechanisms of ejaculation. Basic Life Sci 4: 99-110.
107. Marson L, McKenna KE (1990). The identification of a brainstem site controlling spinal sexual reflexes in male rats. Brain Res 515: 303-308.
108. Masiran R, Sidi H, Mohamed Z et al. (2013 Apr). Association between 5HT2A polymorphism and selective serotonin re-uptake inhibitor (SSRI)-induced sexual desire disorder (SDD) among Malaysian women. Asia Pac Psychiatry 5 (Suppl 1): 41-49.
109. Mathew RJ, Weinman ML (1982). Sexual dysfunctions in depression. Arch Sex Behav 11: 323-328.
110. McCann E (2010). The sexual and relationship needs of people who experience psychosis: quantitative findings of a UK study. J Psychiatr Ment Health Nurs 17: 295-303.
111. McEvoy J, Hatcher A, Appelbaum PS et al. (1983). Chronic schizophrenic women's attitudes toward sex, pregnancy, birth control and childrearing. Hosp Community Psychiatry 43: 536-539.
112. McGlashan TH, Bardenstein KK (1990). Gender differences in affective, schizoaffective and schizophrenic disorders. Schizophr Bull 16: 319-329.
113. McKenna KE, Chung SK, McVary KT (1991). A model for the study of sexual function in anesthetized male and female rats. Am J Physiol 261: R1276-R1285.
114. McMahon CG, Althof SE, Waldinger MD et al. (2008). Anevidence-based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine (ISSM) ad hoc committee for the definition of premature ejaculation. J Sex Med 5: 1590-1606.
115. Measom MO (1992). Penile anesthesia and fluoxetine (letter). Am J Psychiatry 149: 709.
116. Meston CM, Frohlich PF (2000). The neurobiology of sexual function. Arch Gen Psychiatry 57: 1012-1030.
117. Mialon A, Berchtold A, Michaud PA et al. (2012). Sexual dysfunctions among young men: prevalence and associated factors. J Adolesc Health 51: 25-31.
118. Michael A, Andrews S (2002). Paroxetine-induced vaginal anaesthesia. Pharmacopsychiatry 35: 150-151.
119. Michael A, Mayer C (2000). Fluoxetine-induced anaesthesia of vagina and nipples. Br J Psychiatry 176: 299.
120. Mitchell WB, DiBartolo PM, Brown TA et al. (1998). Effects of positive and negative mood on sexual arousal in sexually functional males. Arch Sex Behav 27: 197-207.
121. Monteiro WO, Noshirvani HF, Marks IM et al. (1987). Anorgasmia from clomipramine in obsessive compulsive disorder: a controlled trial. Br J Psychiatry 151: 107-112.
122. Montejo A, Majadas S, Rizvi SJ et al. (2011). The effects of agomelatine on sexual function in depressed patients and healthy volunteers. Hum Psychopharmacol 26: 537-542.
123. Morgan CD, Wiederman MW, Pryor TL (1995). Sexual functioning and attitudes of eating-disordered women: a followup study. J Sex Marital Ther 21: 67-77.
124. Mos J, Mollet I, Tolboom JTBM et al. (1999). A comparison of the effects of different serotonin reuptake blockers on sexual behaviour of the male rat. Eur Neuropsychopharmacol 9: 123-135.
125. Moser DA, Aue T, Suardi F et al. (2014 Jul 25). Violencerelated PTSD and neural activation when seeing emotionally charged male-female interactions. Soc Cogn Affect Neurosci [Epub ahead of print].
126. Murphy MR, Checkley SA, Seckl JR et al. (1990). Naloxone inhibits oxytocin release at orgasm in man. J Clin Endocrinol Metab 71: 1056-1058.
127. Murray CJ, Lopez AD (1997). Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet 349: 1436-1442.
128. Neill JR (1991). Penile anesthesia associated with fluoxetine us (letter). Am J Psychiatry 148: 1603.
129. Nelson JC, Lu Pritchett Y, Martynov O et al. (2006). The safety and tolerability of duloxetine compared with paroxetine and placebo: a pooled analysis of 4 clinical trials. Primary Care Companion. J Clin Psychiatry 8: 212-219.
130. Nicholson J, Geller JL, Fisher WH (1996). "Sylvia Frumkin" has a baby: a case story for policymakers. Psych Serv 47: 497-501.
131. Norman J (1948). Evidence and clinical significance of homosexuality in 100 unanalysed cases of dementia precox. J Nerv Ment Dis 108: 484-489.
132. O'Neill M, Kempler B (1969). Approach and avoidance responses of the hysterical personality to sexual stimuli. J Abnorm Psychol 74: 300-305.
133. Ogawa S, Kudo S, Kitsunay Y et al. (1980). Increase in oxytocin secretion at ejaculation in male. Clin Endocrinol (Oxf) 13: 95-97.
134. Olivier B, van Oorschot R, Waldinger MD (1998). Serotonin, serotonergic receptors, selective serotonin reuptake inhibitors and sexual behaviour. Int Clin Psychopharmacol 13 (suppl 6): S9-S14.
135. Olivier B, Chan JS, Pattij T et al. (2006). Psychopharmacology of male rat sexual behavior: modeling human sexual dysfunctions? Int J Impot Res 18 (Suppl 1): S14-S23.
136. Olivier B, Chan JS, Snoeren EM et al. (2011). Differences in sexual behaviour in male and female rodents: role of serotonin. Curr Top Behav Neurosci 8: 15-36.
137. Osvath P, Fekete S, Voros V et al. (2003). Sexual dysfunction among patients treated with antidepressants-a Hungarian retrospective study. Eur Psychiatry 18: 412-414.
138. Pattij T, de Jong TR, Uitterdijk A et al. (2005). Individual differences in male rat ejaculatory behaviour: searching for models to study ejaculation disorders. Eur J Neurosci 22: 724-734.
139. Perelman MA (2011). E r e c t i l e d ys f u nc t i o n a n d d e p r e s s i on: s c r e e n i n g a n d t r e a t m e n t. U r o l C l i n N o r t h A m 38: 125-139.
140. Perryman RL, Thorner MO (1981). The effects of hyperprolactinemia on sexual and reproductive function in men. J Androl 5: 233-242.
141. Peuskens J (1995). Risperidone in the treatment of patients with chronic schizophrenia: a multinational, multicentre, double-blind, parallel group study versus haloperidol. Br J Psychiatry 166: 712-726.
142. Peuskens J, Sienaert P, De Hert M (1998). Sexual dysfunction: the unspoken side effect of antipsychotics. Eur Psychiatry 13: 23s-30s.
143. Pfaus JG, Everitt BJ (1995). The psychopharmacology of sexual behavior. In: FE Bloom, DJ Kupfer (Eds.), Psychopharmacology: The Fourth Generation of Progress, Raven Press, New York, pp. 743-758.
144. Poels S, Bloemers J, van Rooij K et al. (2013). Toward personalized sexual medicine (part 2): testosterone combined with a PDE5 inhibitor increases sexual satisfaction in women with HSDD and FSAD, and a low sensitive system for sexual cues. J Sex Med 10: 810-823.
145. Ponholzer A, Temmi C, Mock K et al. (2005). Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. Eur Urol 47: 80-86.
146. Quinta Gomes AL, Nobre P (2011). Personality traits and psychopathology on male sexual dysfunction: An empirical study. J Sex Med 8: 461-469.
147. Raboch J (1984). The sexual development and life of female schizophrenic patients. Arch Sex Behav 13: 341-349.
148. Raboch J, Faltus F (1991). Sexuality of women with anorexia nervosa. Acta Psychiatr Scand 84: 9-11.
149. Rand EH (1998). Priapism in a patient taking sertraline. J Clin Psychiatry 59: 538.
150. Reich DB, Zanarini MC (2008). Sexual orientation and relationship choice in borderline personality disorder over ten years of prospective follow-up. J Personal Disord 22: 564-572.
151. Rodriguez M, Castro R, Hernandez G et al. (1984). Different roles of catecholaminergic and serotonergic neurons of the medial forebrain on male rat sexual behavior. Physiol Behav 33: 5-11.
152. Rosen RC, Lane RM, Menza M (1999). Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol 19: 67-85.
153. Rosen R, Janssen E, Wiegel M et al. (2006). Psychological and interpersonal correlates in men with erectile dysfunction and their partners: a pilot study of treatment outcome with sildenafil. J Sex Marital Ther 32: 215-234.
154. Sanchez C, Asin KE, Artigas F (2014). Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data. Pharmacol Ther (in press).
155. Sansone RA, Wiederman MW (2009). Borderline personality symptomatology, casual sexual relationships, and promiscuity. Psychiatry (Edgmont) 6: 36-40.
156. Sansone RA, Chu JW, Wiederman MW (2011a). Sexual behaviour and borderline personality disorder among female psychiatric inpatients. Int J Psychiatry 15: 69-73.
157. Sansone RA, Lam C, Wiederman MW (2011b). The relationship between borderline personality disorder and number of sexual partners. J Personal Disord 25: 782-788.
158. Schiavi RC, Segraves RT (1995). The biology of sexual function. Psychiatr Clin North Am 18: 7-23.
159. Schulte-Herbruggen O, Ahlers CJ, Kronsbein JM et al. (2009). Impaired sexual function in patients with borderline personality disorder is determined by history of sexual abuse. J Sex Med 6: 3356-3363.
160. Segraves RT (1989). Effects of psychotropic drugs on human erection and ejaculation. Arch Gen Psychiatry 46: 275-284.
161. Segraves RT (1992). Sexual dysfunction complicating the treatment of depression. J Clin Psychiatry 10: 75-79.
162. Segraves RT, Balon R (2014). Antidepressant-induced sexual dysfunction in men. Pharmacol Biochem Behav 121: 132-137.
163. Segraves RT, Kavoussi R, Hughes AR et al. (2000). Evaluation of sexual functioning in depressed outpatients: a doubleblind comparison of sustained-release bupropion and sertraline treatment. J Clin Psychopharmacol 20: 122-128.
164. Serefoglu EC, McMahon CG, Waldinger MD et al. (2014). An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second international society for sexual medicine ad hoc committee for the definition of premature ejaculation. J Sex Med 11: 1423-1441.
165. Serretti A, Chiesa A (2009). Treatment-emergent sexual dysfunction related to antidepressants. A meta-analysis. J Clin Psychopharmacol 29: 259-266.
166. Simpson WS, Ramberg JA (1992). Sexual dysfunction in married female patients with anorexia and bulimia nervosa. J Sex Marital Ther 18: 44-45.
167. Skopec HM, Rosenberg SD, Tucker GJ (1976). Sexual behaviour in schizophrenia. Med Aspects Hum Sex 10: 32-47.
168. Smith JM (1980). Abuse of the antiparkinson drugs: a review of the literature. J Clin Psychiatry 41: 351-354.
169. Smith SM, O'Keane V, Murray R (2002). Sexual dysfunction in patients taking conventional antipsychotic medication. Br J Psychiatry 181: 49-55.
170. Snoeren EM, Veening JG, Olivier B et al. (2014). Serotonin 1A receptors and sexual behavior in male rats: a review. Pharmacol Biochem Behav 121: 102-114.
171. Sobrinho LG, Sa-Melo P, Nunes MCP et al. (1987). Sexual dysfunction of hyperprolactinaemic women, effects of bromocriptine. J Psychosom Obstet Gynaecol 6: 43-48.
172. Staebler C, Pollard CA (1993). Sexual history and quality of current relationships in patients with obsessive compulsive disorder: a comparison with two other psychiatric samples. J Sex Marital Ther 19: 147-153.
173. Steketee G (1997). Disability and family burden in obsessive - compulsive disorder. Can J Psychiatry 42: 919-928.
174. Strauss B, Gross J (1984). Psychopharmaka bedingte Veranderungen der Sexualitat (Haufigkeit und Stellwert in der psychiatrischen Praxis). Psychiatr Prax 11: 49-55.
175. Thase ME, Reynolds III CF, Jennings JR et al. (1988). Nocturnal penile tumescence is diminished in depressed men. Biol Psychiatry 24: 33-46.
176. Thase ME, Reynolds III CF, Jennings JR et al. (1992). Diminished nocturnal penile tumescence in depression: a replication study. Biol Psychiatry 31: 1136-1142.
177. Thase ME, Clayton AH, Haight BR et al. (2006). A doubleblind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy and tolerability. J Clin Psychopharmacol 26: 482-488.
178. Truitt WA, Coolen LM (2002). Identification of a potential ejaculation generator in the spinal cord. Science 297: 1566-1569.
179. Tuiten A, Panhuysen G, Everaerd W et al. (1993). The paradoxical nature of sexuality in anorexia nervosa. J Sex Marital Ther 19: 259-275.
180. Valevski A, Modai I, Zbarski E et al. (1998). Effect of amantadine on sexual dysfunction in neuroleptic-treated male schizophrenic patients. Clin Neuropharmacol 21: 355-357.
181. Van Minnen A, Kampman M (2000). Interaction between anxiety and sexual functioning: a controlled study of sexual functioning in women with anxiety disorders. Sexual and Relationship Therapy 15: 47-57.
182. van Rooij K, Poels S, Bloemers J et al. (2013). Toward personalized sexual medicine (part 3): testosterone combined with a Serotonin1A receptor agonist increases sexual satisfaction in women with HSDD and FSAD, and dysfunctional activation of sexual inhibitory mechanisms. J Sex Med 10: 824-837.
183. Veening JG, Coolen LM (1998). Neural activation following sexual behavior in the male and female rat brain. Behav Brain Res 92: 181-193.
184. Veening JG, Coolen LM (2014 Jun). Neural mechanisms of sexual behavior in the male rat: emphasis on ejaculationrelated circuits. Pharmacol Biochem Behav 121: 170-183.
185. Veening JG, Coolen LM, Gerrits PO (2014 Jun). Neural mechanisms of female sexual behavior in the rat; comparison with male ejaculatory control. Pharmacol Biochem Behav 121: 16-30.
186. Vulink NCC, Denys D, Bus L et al. (2006). Sexual pleasure in women with obsessive compulsive disorder. J Affect Disord 91: 19-25.
187. Waldinger MD (1996). Use of psychoactive agents in the treatment of sexual dysfunction. CNS Drugs 6: 204-216.
188. Waldinger MD, Schweitzer DH (2009). Persistent genital arousal disorder in 18 Dutch women: Part II. A syndrome clustered with restless legs and overactive bladder. J Sex Med 6: 482-497.
189. Waldinger MD, Hengeveld MW, Zwinderman AH (1994). Paroxetine treatment of premature ejaculation: a double-blind, randomized, placebo-controlled study. Am J Psychiatry 151: 1377-1379.
190. Waldinger MD, Hengeveld MW, Zwinderman AH et al. (1998). A double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine and sertraline. J Clin Psychopharmacol 18: 274-281.
191. Waldinger MD, van de Plas A, Pattij T et al. (2002). The selective serotonin re-uptake inhibitors fluvoxamine and paroxetine differ in sexual inhibitory effects after chronic treatment. Psychopharmacology (Berl) 160: 283-289.
192. Waldinger MD, Zwinderman AH, Schweitzer DH et al. (2004). Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. Int J Impot Res 16: 369-381.
193. Waldinger MD, Zwinderman AH, Olivier B et al. (2008). Geometric mean IELT and premature ejaculation: appropriate statistics to avoid overestimation of treatment efficacy. J Sex Med 5: 492-499.
194. Waldinger MD, van Gils AP, Ottervanger HP et al. (2009). Persistent genital arousal disorder in 18 Dutch women: Part I. MRI, EEG, and transvaginal ultrasonography investigations. J Sex Med 6: 474-481.
195. Waldinger MD, de Lint GJ, Venema PL et al. (2010). Successful transcutaneous electrical nerve stimulation in two women with restless genital syndrome: the role of A-delta- and C-nerve fibers. J Sex Med 7: 1190-1199.
196. Waldinger MD, Venema PL, van Gils AP et al. (2011 Jan). Stronger evidence for small fiber sensory neuropathy in restless genital syndrome: two case reports in males. J Sex Med 8 (1): 325-330.
197. Waldinger MD, van Coevorden RS, Schweitzer DH et al. (2014). Post-SSRI sexual dysfunction (PSSD) responds to low-power laser irradiation: a case study and hypothesis about the role of transient receptor potential (TRP) ion channels. Eur J Pharmacol (in press).
198. Wein AJ, van Arsdalen KN (1988). Drug-induced male sexual function. Impotence 15: 23-31.
199. Wignall CM, Meredith CE (1968). Illegitimate pregnancies in state institutions. Arch Gen Psychiatry 18: 580-583.
200. Williams K, Reynolds MF (2006). Sexual dysfunction in major depression. CNS Spectr 11 (8 Suppl 9): 19-23.
201. World Health Organization (1978). International Classification of Diseases (ICD-9-CM). Manual of the international statistical classification of diseases, 9th revision, clinical modification, Volume 2. World Health Organization, Geneva.
202. Yang JC (2004). Functional neuroanatomy in depressed patients with sexual dysfunction: blood oxygenation level dependent functional MR imaging. Korean J Radiol 5: 87-95.
203. Yang JC, Park K, Eun SJ et al. (2008). Assessment of cerebocortical areas associated with sexual arousal in depressive women using functional MR imaging. J Sex Med 5: 602-609.
204. Zanarini MC, Frankenburg FR, Reich DB et al. (1999). Violence in the lives of adult borderline patients. J Nerv Ment Dis 187: 65-71.
205. Zanarini MC, Parachini EA, Frankenburg FR et al. (2003). Sexual relationship difficulties among borderline patients and axis II comparison subjects. J Nerv Ment Dis 191: 479-482.
206. Zegerius L, Waldinger MD (2000). De neurobiologische Basis van de Psychoanalyse. Tijdschr Psychiatr 42: 675-683.
207. Zemishlany Z, Weizman A (2008). The impact of mental illness on sexual dysfunction. In: R Balon (Ed.), Sexual Dysfunction. The Brain-Body Connection. Adv Psychosom Med, vol 29. Karger, Basel, pp. 89-106.